| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |